Cargando…

PAR4 (Protease-Activated Receptor 4) Antagonism With BMS-986120 Inhibits Human Ex Vivo Thrombus Formation

OBJECTIVE—: BMS-986120 is a novel first-in-class oral PAR4 (protease-activated receptor 4) antagonist with potent and selective antiplatelet effects. We sought to determine for the first time, the effect of BMS-986120 on human ex vivo thrombus formation. APPROACH AND RESULTS—: Forty healthy voluntee...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wilson, Simon J., Ismat, Fraz A., Wang, Zhaoqing, Cerra, Michael, Narayan, Hafid, Raftis, Jennifer, Gray, Timothy J., Connell, Shea, Garonzik, Samira, Ma, Xuewen, Yang, Jing, Newby, David E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2018
Materias:	Translational Sciences
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5779320/ https://www.ncbi.nlm.nih.gov/pubmed/29269513 http://dx.doi.org/10.1161/ATVBAHA.117.310104

Ejemplares similares

Antithrombotic Effects of Combined PAR (Protease-Activated Receptor)-4 Antagonism and Factor Xa Inhibition
por: Meah, Mohammed N., et al.
Publicado: (2020)

Genetic Variant in Human PAR (Protease-Activated Receptor) 4 Enhances Thrombus Formation Resulting in Resistance to Antiplatelet Therapeutics
por: Tourdot, Benjamin E., et al.
Publicado: (2018)

Dapagliflozin: BMS 512148; BMS-512148
Publicado: (2012)

A KLK4 proteinase substrate capture approach to antagonize PAR1
por: Rabinovitch, Eitan, et al.
Publicado: (2021)

BMS-690514, a VEGFR and EGFR tyrosine kinase inhibitor, shows anti-tumoural activity on non-small-cell lung cancer xenografts and induces sequence-dependent synergistic effect with radiation
por: Loriot, Y, et al.
Publicado: (2010)

The γ-Secretase Modulator, BMS-932481, Modulates Aβ Peptides in the Plasma and Cerebrospinal Fluid of Healthy Volunteers
por: Soares, Holly D., et al.
Publicado: (2016)

Organ-specific inhibition of metastatic colon carcinoma by CXCR3 antagonism
por: Cambien, B, et al.
Publicado: (2009)

BMS-599626, a Highly Selective Pan-HER Kinase Inhibitor, Antagonizes ABCG2-Mediated Drug Resistance
por: Ashar, Yunali V., et al.
Publicado: (2020)

Crystal structures of trimeric HIV Env with entry inhibitors BMS-378806 and BMS-626529
por: Pancera, Marie, et al.
Publicado: (2017)

Neuropilin-1 antagonism in human carcinoma cells inhibits migration and enhances chemosensitivity
por: Jia, H, et al.
Publicado: (2010)

PAR-4 overcomes chemo-resistance in breast cancer cells by antagonizing cIAP1
por: Guo, Haihong, et al.
Publicado: (2019)

Barrel-muon-spectrometer: BMS
Publicado: (2005)

Barrel-muon-spectrometer: BMS
Publicado: (2005)

Barrel-muon-spectrometer: BMS
Publicado: (2005)

Barrel-muon-spectrometer: BMS
Publicado: (2005)

Barrel-muon-spectrometer: BMS
Publicado: (2005)

Barrel-muon-spectrometer: BMS
Publicado: (2005)

Barrel-muon-spectrometer: BMS
Publicado: (2005)

Antagonism between granulocytic maturation and deacetylase inhibitor-induced apoptosis in acute promyelocytic leukaemia cells
por: Hennig, D, et al.
Publicado: (2015)

Funding Research Through the Online Partnership to Accelerate Research (OnPAR)
por: Dueñas, Martin A., et al.
Publicado: (2016)

Circadian nuclear receptor Rev-erbα is expressed by platelets and potentiates platelet activation and thrombus formation
por: Shi, Jianfeng, et al.
Publicado: (2022)

Construction of the MPI BMS Prototype Chamber
por: Bratzler, U, et al.
Publicado: (1997)

Platelet-derived MMP-2 in the prevention of plaque formation: how many strokes is par?
por: Cosemans, Judith M E M
Publicado: (2021)

FABP4 inhibitors 3D-QSAR model and isosteric replacement of BMS309403 datasets
por: Floresta, Giuseppe, et al.
Publicado: (2018)

Claparède (1904) on Monocular Stereopsis: History, Theory, and Translation
por: O’Shea, Robert P.
Publicado: (2017)

Altered expression of caspases-4 and -5 during inflammatory bowel disease and colorectal cancer: Diagnostic and therapeutic potential
por: Flood, B, et al.
Publicado: (2015)

BMS1 Is Mutated in Aplasia Cutis Congenita
por: Marneros, Alexander G.
Publicado: (2013)

Ragona-Scinà’s (1847) Method for, and Observations of, Simultaneous Color Contrast
por: O’Shea, Robert P., et al.
Publicado: (2016)

On the Discovery of Monocular Rivalry by Tscherning in 1898: Translation and Review
por: O’Shea, Robert P., et al.
Publicado: (2017)

Gottfried Wilhelm Osann (1833, 1836) on Simultaneous Color Contrast: Translation and Commentary
por: O’Shea, Robert P., et al.
Publicado: (2017)

Prognostic Value of Histopathological Thrombus Age in Large Vessel Occlusion-Related Stroke
por: van Gorsel, Bart, et al.
Publicado: (2023)

The Discovery and Early Clinical Evaluation of the HCV NS3/4A Protease Inhibitor Asunaprevir (BMS-650032)
por: Meanwell, Nicholas A., et al.
Publicado: (2018)

Failure to Launch: Targeting Inflammation in Acute Coronary Syndromes
por: Rymer, Jennifer A., et al.
Publicado: (2017)

COL4A3 Mutation Induced Podocyte Apoptosis by Dysregulation of NADPH Oxidase 4 and MMP-2
por: Tong, Jun, et al.
Publicado: (2023)

Role of Mitochondrial Toxicity in BMS-986094-Induced Toxicity
por: Feng, Joy Y., et al.
Publicado: (2017)

Effect of BMS-470539 on lipopolysaccharide-induced neutrophil activation
por: Lee, Seongheon, et al.
Publicado: (2020)

Activated 4E-BP1 represses tumourigenesis and IGF-I-mediated activation of the eIF4F complex in mesothelioma
por: Jacobson, B A, et al.
Publicado: (2009)

Elucidation of the assembly events required for the recruitment of Utp20, Imp4 and Bms1 onto nascent pre-ribosomes
por: Pérez-Fernández, Jorge, et al.
Publicado: (2011)

The effects of trastuzumab on the CD4+CD25+FoxP3+ and CD4+IL17A+ T-cell axis in patients with breast cancer
por: Horlock, C, et al.
Publicado: (2009)

Expression of thymidylate synthase in human cells is an early G(1) event regulated by CDK4 and p16INK4A but not E2F
por: Le François, B G, et al.
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_svipvippj0ov3fui8qj6k15gsq